Building on our core competencies in business strategy, Health Advances’ Global Market Access and Pricing Practice supports clients in developing value-creating commercialization and pipeline strategies to enable patient access to innovative therapies, diagnostics, digital tools and devices and achieve favorable pricing that reflects the product’s value proposition and rewards innovations.

Our Advantage: Strategic Lens and Global Practice Across Sectors and Settings

Our leaders combine decades of consulting and industry experience across five sectors of the healthcare industry with an in-depth understanding of the global and local payer landscape to deliver actionable and achievable market access and pricing strategies.

In addition to our cross-sector expertise, Health Advances brings deep strategic insights into your market access business needs across healthcare settings and in areas of convergence such as companion diagnostics, drug delivery, and digital health.

Capability Leaders

Dr. Holger Müller
Vice President, Biopharma

Darcy Krzynowek
Vice President, Medtech

Jeffrey Abraham
Vice President, Health IT and Digital Health

Kelly Cockerill
Vice President, Biopharma and Business Development

View our Global Market Access and Pricing Strategy case examples.